close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. William Tester

location-icon

Philadelphia, PA

LOCATION OF PRACTICE
Jefferson Health
MEDICAL Specialty:

Prostate Cancer



NPI Number
1386613693
ABOUT

William J. Tester, MD, FACP is Vice Chairman of Clinical Operations and Director of Bladder Cancer Research at Thomas Jefferson University. Dr. Tester’s clinical research focuses on muscle-invasive bladder cancer (MIBC), non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC). He is actively involved in clinical trials, including the AMBASSADOR study, which investigates the use of pembrolizumab in MIBC, and the ALCHEMIST trial, which explores adjuvant therapies for early-stage lung cancer. Additionally, he has co-authored studies on circulating tumor cells as prognostic markers in metastatic castration-resistant prostate cancer.

Dr. William Tester profile image

Published Articles

Renal cell carcinoma: entering the age of biomarkers.- 2024 Aug
T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer.- 2024 Dec 31
Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma.- 2024 Apr 22
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.- 2024 Jun
Enhancing bladder cancer care through the multidisciplinary clinic approach.- 2023 Jun
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.- 2022 Nov 1
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.- 2021 Jun
Incidental early diagnosis of biphasic pulmonary blastoma in a patient with history of stage IV lung adenocarcinoma.- 2020 Oct
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.- 2020 Aug 20
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.- 2017 Dec

Clinical Trials

TR(ACE) Assay Clinical Specimen Study
The Zeaxanthin and Visual Function Study
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected
The Effect of High Intensity Laser on Muscle Quality and Pain in Those With Low Back Pain

My Patient Resources

Other Specialists treating Prostate Cancer in Philadelphia, PA

See All Doctors

Dr. Naomi Haas

Specialty: Retroperitoneum Cancer, Kidney Cancer, Prostate Cancer

My Resources
location-icon

Chester County Hospital

My Resources

Dr. Mary Daly

Specialty: Breast Cancer, Prostate Cancer, Uterine Cancer

My Resources
location-icon

Temple University Hospital

My Resources

Dr. Alvaro Pereira-Rico

Specialty: Prostate Cancer, Bone Cancer, Metastatic Respiratory System Cancer

My Resources
location-icon

Lancaster General Hospital

My Resources

Dr. Eric Gressen

Specialty: Uterine Cancer, Prostate Cancer, Brain Cancer

My Resources
location-icon

Thomas Jefferson University Hospital

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider